Advocacy intelligence hub — real-time data for patient organizations
VA Office of Research and Development — NA
University of Rochester — PHASE2
VA Office of Research and Development — NA
VA Office of Research and Development — NA
VA Office of Research and Development — NA
Institute of Hematology & Blood Diseases Hospital, China — PHASE1
First Affiliated Hospital of Zhejiang University — PHASE2
VA Office of Research and Development — NA
University Hospital, Strasbourg, France
Stanford University — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Tapan M Kadia
M D Anderson Cancer Center
📍 Houston, Texas
Liang Wang, M.D.
Beijing Tongren Hospital
Roland Walter, MD PhD
Fred Hutch/University of Washington Cancer Consortium
📍 SEATTLE, WA
Sheng-Li Xue, M.D.
The First Affiliated Hospital of Soochow University
Xin Zhao, MD
Institute of Hematology & Blood Diseases Hospital
📍 Tianjin
Theodosia Kalfa, MD, PhD, M.D
Children's Hospital Medical Center, Cincinnati
📍 CINCINNATI, OH